ACL australian clinical labs limited

Ann: Upgraded FY21 earnings guidance by 10 to 15%, page-2

  1. 769 Posts.
    lightbulb Created with Sketch. 130
    Well hopefully this very positive announcement gets us back to IPO issue price. Very good EBITDA and and NPAT margins

 
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)
Last
$2.82
Change
-0.010(0.35%)
Mkt cap ! $553.8M
Open High Low Value Volume
$2.83 $2.83 $2.78 $1.879M 670.7K

Buyers (Bids)

No. Vol. Price($)
1 1071 $2.80
 

Sellers (Offers)

Price($) Vol. No.
$2.83 2376 2
View Market Depth
Last trade - 16.14pm 29/07/2025 (20 minute delay) ?
ACL (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.